Cash flows from operating activities: | |
Net income | 48.36M |
Adjustments to reconcile net income to net cash provided by operating activities: | |
Depreciation and amortization | 20.53M |
Loss on disposition of property and equipment | 1.11M |
Impairment | |
Share-based compensation | 1.43M |
Excess tax benefit from share-based compensation | -1.06M |
Changes in assets and liabilities: | |
Inventories | -34.91M |
Other current assets | |
Accounts payable | -13.48M |
Accrued employee compensation | |
Deferred revenue | |
Other current liabilities | |
Other long-term assets and liabilities | |
Net cash provided by operating activities | 34.94M |
Cash flows from investing activities: | |
Purchase of property and equipment | -26.41M |
Proceeds from sale of property and equipment | 265K |
Proceeds from insurance recoveries of property and equipment | 74K |
Net cash used in investing activities | -26.07M |
Cash flows from financing activities: | |
Proceeds from issuance of long-term debt | |
Principal payments under long-term debt and other long-term obligations | |
Proceeds from exercise of share-based compensation awards | |
Excess tax benefit from share-based compensation | 1.06M |
Purchases and retirement of common stock | 0 |
Deferred financing costs | |
Dividends on common stock | -29.65M |
Net cash used in financing activities | -34.73M |
Net increase in cash and cash equivalents | |
Cash and cash equivalents, beginning of period | 150.97M |
Cash and cash equivalents, end of period | 125.11M |
Cash paid during the period for: | |
Interest, excluding interest rate swap payments, net of amounts capitalized | 3.16M |
Interest rate swaps | |
Income taxes | 784K |
Supplemental schedule of non-cash financing activity: | |
Change in fair value of interest rate swaps | 6.11M |
Change in deferred tax asset for interest rate swaps | -2.34M |